Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis

[1]  T. Kuhlmann,et al.  Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. , 2020, Brain : a journal of neurology.

[2]  K. Fujihara,et al.  Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. , 2020, Brain : a journal of neurology.

[3]  C. Lucchinetti,et al.  The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody , 2020, Acta Neuropathologica.

[4]  Jacqueline Palace,et al.  International multicenter examination of MOG antibody assays , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[5]  S. Broadley,et al.  Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination , 2019, Acta Neuropathologica Communications.

[6]  M. Reindl,et al.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease , 2018, Nature Reviews Neurology.

[7]  G. Krishnamoorthy,et al.  Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein , 2018, Annals of neurology.

[8]  H. Lassmann,et al.  The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells , 2018, Brain : a journal of neurology.

[9]  H. Lassmann,et al.  Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination , 2017, Journal of Neuroinflammation.

[10]  A. Langerak,et al.  Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients , 2017, Acta Neuropathologica.

[11]  Siegfried Trattnig,et al.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging , 2016, Acta Neuropathologica.

[12]  H. Lassmann,et al.  Multiple sclerosis: experimental models and reality , 2016, Acta Neuropathologica.

[13]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome , 2016, Journal of Neuroinflammation.

[14]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin , 2016, Journal of Neuroinflammation.

[15]  T. Olsson,et al.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins , 2016, Proceedings of the National Academy of Sciences.

[16]  R. Hohlfeld,et al.  The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research , 2016, The Lancet Neurology.

[17]  W. Brück,et al.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain , 2016, Brain : a journal of neurology.

[18]  R. Hohlfeld,et al.  The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets , 2016, The Lancet Neurology.

[19]  H. Lassmann,et al.  Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis. , 2016, Methods in molecular biology.

[20]  H. Lassmann,et al.  Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ? , 2015, Acta Neuropathologica Communications.

[21]  Mikhail Pogorelyy,et al.  VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires , 2015, PLoS Comput. Biol..

[22]  M. Reindl,et al.  Antibody biomarkers in CNS demyelinating diseases – a long and winding road , 2015, European journal of neurology.

[23]  Mikhail Shugay,et al.  Towards error-free profiling of immune repertoires , 2014, Nature Methods.

[24]  A. Bar-Or,et al.  Distinction and Temporal Stability of Conformational Epitopes on Myelin Oligodendrocyte Glycoprotein Recognized by Patients with Different Inflammatory Central Nervous System Diseases , 2013, The Journal of Immunology.

[25]  Jacqueline A Palace,et al.  Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype , 2012, Neurology.

[26]  J. Sejvar,et al.  An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study , 2010, The Lancet Neurology.

[27]  R. Huber,et al.  Demyelinating Myelin Oligodendrocyte Glycoprotein-Specific Autoantibody Response Is Focused on One Dominant Conformational Epitope Region in Rodents12 , 2008, The Journal of Immunology.

[28]  A. Perelson,et al.  Polyspecificity of T cell and B cell receptor recognition. , 2007, Seminars in immunology.

[29]  A. Bar-Or,et al.  Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein , 2007, Nature Medicine.

[30]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[31]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[32]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[33]  Y. Sugisaki,et al.  Reversing the Effects of Formalin Fixation with Citraconic Anhydride and Heat: A Universal Antigen Retrieval Method , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  F. Seitelberger,et al.  Akute tödliche Entmarkungs-Encephalitis nach wiederholten Hirntrockenzellen-Injektionen , 2005, Klinische Wochenschrift.

[35]  R. Huber,et al.  Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Lassmann,et al.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.

[37]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[38]  H. Lassmann,et al.  Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) , 1987, Journal of Neuroimmunology.

[39]  M. Webb,et al.  A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody , 1984, Journal of Neuroimmunology.

[40]  Dr. med. Hans Lassmann.  Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 1983, Schriftenreihe Neurologie / Neurology Series.

[41]  S. H. Stone,et al.  CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS * , 1965, Annals of the New York Academy of Sciences.

[42]  K. Jellinger,et al.  [Acute fatal demyelinizing encephalitis after repeated injections of dry brain cells]. , 1958, Klinische Wochenschrift.

[43]  H. Shiraki,et al.  A CONTRIBUTION TO THE CLASSIFICATION AND THE PATHOGENESIS OF DEMYLELINATING EXCEPHALOMYELITIS WITH SPECIAL REFERENCE TO THE CENTIRM, NERVOOS SYSTEM LESIONS CAUSED BY PREVENTIVE INOCULATION AGAINST RABIES , 1957, Journal of neuropathology and experimental neurology.

[44]  T. Rivers,et al.  OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.

[45]  G. Stuart,et al.  The Neuro-Paralytic Accidents of Anti-Rabies Treatment , 1928 .

[46]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.